These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37722463)

  • 41. Identifying high-risk profile in primary antiphospholipid syndrome through cluster analysis: French multicentric cohort study.
    Guedon AF; Ricard L; Laurent C; De Moreuil C; Urbanski G; Deriaz S; Gerotziafas G; Elalamy I; Audemard A; Chasset F; Alamowitch S; Sellam J; Boffa JJ; Cohen A; Wahl C; Abisror N; Maillot F; Fain O; Mekinian A
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36894193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Childhood-onset systemic lupus erythematosus-related antiphospholipid syndrome: A multicenter study with 1519 patients.
    Islabão AG; Mota LMH; Ribeiro MCM; Arabi TM; Cividatti GN; Queiroz LB; Andrade DC; Sakamoto AP; Trindade VC; Novak GV; Molinari BC; Campos LM; Aikawa NE; Pereira RMR; Terreri MT; Magalhães CS; Marini R; Gomes HR; Silva MF; Oliveira SK; Sztajnbok FR; Sacchetti SB; Bica BE; Sena EG; Moraes AP; Santos MC; Robazzi TC; Spelling PF; Scheibel IM; Cavalcanti AS; Naka EN; Guimarães LJ; Santos FP; Sampaio MC; Bonfá E; Silva CA;
    Autoimmun Rev; 2020 Dec; 19(12):102693. PubMed ID: 33164791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffuse Alveolar Hemorrhage in Autoimmune Diseases.
    Martínez-Martínez MU; Oostdam DAH; Abud-Mendoza C
    Curr Rheumatol Rep; 2017 May; 19(5):27. PubMed ID: 28397125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center.
    Serrano R; Pons-Estel GJ; Espinosa G; Quintana RM; Reverter JC; Tassies D; Monteagudo J; Cervera R
    Lupus; 2020 Aug; 29(9):1050-1059. PubMed ID: 32536318
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiphospholipid-associated thrombocytopenia or autoimmune hemolytic anemia in patients with or without definite primary antiphospholipid syndrome according to the Sapporo revised classification criteria: a 6-year follow-up study.
    Comellas-Kirkerup L; Hernández-Molina G; Cabral AR
    Blood; 2010 Oct; 116(16):3058-63. PubMed ID: 20625007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus.
    Martínez-Martínez MU; Abud-Mendoza C
    Lupus; 2011 May; 20(6):568-74. PubMed ID: 21558137
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome].
    Gu JY; Lu C; Shi H; Yang CD
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A spontaneous intercostal artery hemorrhage in systemic lupus erythematosus.
    Lu CC; Chen CH; Yeh SF; Lai JH; Chang DM
    Rheumatol Int; 2012 Mar; 32(3):829-31. PubMed ID: 21336530
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort.
    Pires da Rosa G; Ferreira E; Sousa-Pinto B; Bettencourt P; Espinosa G; Cervera R
    Scand J Rheumatol; 2023 Mar; 52(2):190-195. PubMed ID: 35723613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffuse alveolar hemorrhage secondary to sarcoidosis.
    Diaz-Menindez M; Sullivan MM; Butendieck RR; Abril A; Majithia V; Wang B; Berianu F
    Clin Rheumatol; 2023 Jun; 42(6):1701-1704. PubMed ID: 36847928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults.
    Tektonidou MG; Andreoli L; Limper M; Tincani A; Ward MM
    RMD Open; 2019; 5(1):e000924. PubMed ID: 31168416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical and prognostic significance of antinuclear antibodies in primary antiphospholipid syndrome: A multicenter retrospective study.
    Ricard L; Laurent C; Papo M; Deriaz S; Catano J; Alamowitch S; Kayem G; Chasset F; De Moreuil C; Boffa JJ; Gerotziafas G; Elalamy I; Bornes M; Maillot F; Audemard-Verger A; Planche V; Ballot E; Fain O; Mekinian A
    Joint Bone Spine; 2022 Mar; 89(2):105297. PubMed ID: 34656751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
    Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012169. PubMed ID: 28968483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors of diffuse alveolar hemorrhage in Chinese patients with systemic lupus erythematosus.
    Xu L; Yang R; Cao Y; Wang M; Yang X
    Sci Rep; 2023 Dec; 13(1):22381. PubMed ID: 38104153
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Diffuse alveolar hemorrhage in systemic lupus erythematosus].
    Shen M; Zeng XJ; Fan HW; Xu WB; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):201-3. PubMed ID: 19537040
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombotic risk factors in patients with antiphospholipid syndrome: a single center experience.
    Abu-Zeinah G; Oromendia C; DeSancho MT
    J Thromb Thrombolysis; 2019 Aug; 48(2):233-239. PubMed ID: 30835035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute pulmonary edema, capillaritis and alveolar hemorrhage: pulmonary manifestations coexistent in antiphospholipid syndrome and systemic lupus erythematosus?
    Nguyen VA; Gotwald T; Prior C; Oberrnoser G; Sepp N
    Lupus; 2005; 14(7):557-60. PubMed ID: 16130514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry").
    Yelnik CM; Erton ZB; Drumez E; Cheildze D; de Andrade D; Clarke A; Tektonidou MG; Sciascia S; Pardos-Gea J; Pengo V; Ruiz-Irastorza G; Belmont HM; Pedrera CL; Fortin PR; Wahl D; Gerosa M; Kello N; Signorelli F; Atsumi T; Ji L; Efthymiou M; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri M; Cervera R; Shi H; Zuo Y; Artim-Esen B; Pons-Estel G; Willis R; Barber MRW; Skeith L; Bertolaccini ML; Cohen H; Roubey R; Erkan D
    Semin Arthritis Rheum; 2024 Apr; 65():152347. PubMed ID: 38185079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.